CATALOGO DEI PRODOTTI DELLA RICERCA

ORSOLINI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.934
NA - Nord America 1.918
AS - Asia 827
SA - Sud America 9
OC - Oceania 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.912
CN - Cina 638
GB - Regno Unito 574
IT - Italia 258
SE - Svezia 211
DE - Germania 193
IE - Irlanda 185
FR - Francia 174
RU - Federazione Russa 164
SG - Singapore 96
FI - Finlandia 73
JP - Giappone 37
UA - Ucraina 31
VN - Vietnam 21
AT - Austria 17
BE - Belgio 16
TR - Turchia 11
ES - Italia 9
KR - Corea 8
IR - Iran 7
NL - Olanda 7
CA - Canada 6
AU - Australia 4
CL - Cile 4
RO - Romania 4
CZ - Repubblica Ceca 3
IN - India 3
AR - Argentina 2
BR - Brasile 2
GR - Grecia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
EC - Ecuador 1
HK - Hong Kong 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
Totale 4.697
Salva come PNG Salva come JPEG
Città #
Southend 555
Chandler 478
Dublin 185
Jacksonville 136
Redmond 134
Ashburn 125
Beijing 120
Ann Arbor 94
Lawrence 70
New York 70
Princeton 70
Wilmington 68
Bologna 67
Singapore 67
Woodbridge 66
Shenyang 54
Jinan 49
Helsinki 44
Nanjing 43
Verona 36
Hebei 34
Tokyo 34
Houston 30
Sindelfingen 30
Tianjin 29
Haikou 25
Ningbo 25
Changsha 23
Zhengzhou 23
Hangzhou 22
Milan 22
Taiyuan 20
Vienna 17
Brussels 16
Washington 16
Nanchang 15
Seattle 15
Norwalk 14
Redwood City 14
Guangzhou 13
Jiaxing 13
Taizhou 13
Venice 12
Dong Ket 11
Fuzhou 11
Dallas 10
Fairfield 10
San Francisco 8
Chicago 7
Denver 7
Kent 7
Seoul 7
Boardman 6
Cagliari 6
Düsseldorf 6
Falls Church 6
Dearborn 5
Lanzhou 5
Nürnberg 5
Bari 4
Cambridge 4
Dongguan 4
Falkenstein 4
Lappeenranta 4
Miami 4
Rome 4
San Mateo 4
Shanghai 4
Turin 4
Ardabil 3
Barcelona 3
Bilbao 3
Brno 3
Detroit 3
Leawood 3
Los Angeles 3
Moscow 3
Palermo 3
Toronto 3
Amsterdam 2
Augusta 2
Benevento 2
Bratislava 2
Brescia 2
Buenos Aires 2
Böblingen 2
Cascina 2
Chiampo 2
Clearwater 2
Esslingen am Neckar 2
Giavera del Montello 2
Giugliano in Campania 2
Gunzenhausen 2
Kemerovo 2
Lancaster 2
Lecce 2
Leverkusen 2
Lucé 2
Luino 2
Mehlingen 2
Totale 3.235
Salva come PNG Salva come JPEG
Nome #
Artrite Reumatoide e Metabolismo Minerale 164
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 146
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 127
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 118
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 109
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 102
Osteoporosis treatment: why ibandronic acid? 101
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 99
Anti-CCP antibodies and bone 99
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 95
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 94
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 90
Bone involvement and osteoporosis in mastocytosis. 88
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 85
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 84
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 83
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 83
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 82
Rheumatoid arthritis, γδ T cells and bisphosphonates 80
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy. 79
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 79
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
BIOMARKERS LABORATORISTICI RELATIVI AL COINVOLGIMENTO OSSEO NELLE ARTROPATIE INFIAMMATORIE 77
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 77
Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece? 76
Bone Disease in Mastocytosis 74
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 71
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 70
Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients? 70
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 69
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 68
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 67
High prevalence of occult heart disease in normotensive patients with rheumatoid arthritis 66
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 66
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 66
Association between environmental air pollution and rheumatoid arthritis flares 66
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 64
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 62
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 61
Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study 60
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 57
Osteoporosis in Rheumatic Diseases 57
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 53
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 53
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 51
Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients 51
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 51
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 50
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 50
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 48
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 47
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 47
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 46
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 45
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 44
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network 44
Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction 43
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 42
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 42
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 41
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 40
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 39
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 35
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 35
Incidence and predictors of new onset left ventricular diastolic dysfunction in asymptomatic patients with rheumatoid arthritis without overt cardiac disease 34
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 33
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 28
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 26
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 26
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 25
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 23
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement 22
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 21
Subclinical Myocardial Fibrosis in Systemic Lupus Erythematosus as Assessed by Pulse-Cancellation Echocardiography: A Pilot Study 20
Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis 20
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 19
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 19
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 16
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 10
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 8
Changes in bone turnover markers and bone modulators during abatacept treatment 8
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 7
Totale 4.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.088
article - articoli 18.857
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 231
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020386 0 0 7 38 49 59 57 18 40 29 33 56
2020/2021724 101 118 24 130 102 53 28 8 44 3 68 45
2021/2022602 56 166 10 40 23 8 19 27 58 10 40 145
2022/20231.332 83 147 105 246 120 311 18 66 167 11 46 12
2023/2024757 32 60 70 90 77 146 30 40 13 26 134 39
2024/2025187 82 103 2 0 0 0 0 0 0 0 0 0
Totale 4.871